Prellis Biologics ( SOSV Accelerator)
Funding Details
Awarder
SOSV
Date Award
May 13, 2024
Vertical
Biopharma
Funding URL
View Funding Page
Company Info
Founders
Melanie Matheu, Kevin Chapman, Yelda Kaya, Matt Niemiec
Market
Human Health
Location
United States
Company Description

Prellis is leveraging their unique approach to tissue engineering to support the first use of synthetic human tissue for de novo therapeutic antibody discovery.

Links
WebsiteCrunchbaseLinkedInTwitter
Back to HomeBack to Biopharma DealsView Funding Announcement